These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 8957930)

  • 1. Osteoclast activation in inflammatory periodontal diseases.
    Wiebe SH; Hafezi M; Sandhu HS; Sims SM; Dixon SJ
    Oral Dis; 1996 Jun; 2(2):167-80. PubMed ID: 8957930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence that diabetes mellitus aggravates periodontal diseases and modifies the response to an oral pathogen in animal models.
    Graves DT; Al-Mashat H; Liu R
    Compend Contin Educ Dent; 2004 Jul; 25(7 Suppl 1):38-45. PubMed ID: 15645885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of cytokines in the pathogenesis of periodontal disease.
    Alexander MB; Damoulis PD
    Curr Opin Periodontol; 1994; ():39-53. PubMed ID: 8032465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic syndrome exacerbates inflammation and bone loss in periodontitis.
    Li Y; Lu Z; Zhang X; Yu H; Kirkwood KL; Lopes-Virella MF; Huang Y
    J Dent Res; 2015 Feb; 94(2):362-70. PubMed ID: 25503900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective blockade of voltage-gated potassium channels reduces inflammatory bone resorption in experimental periodontal disease.
    Valverde P; Kawai T; Taubman MA
    J Bone Miner Res; 2004 Jan; 19(1):155-64. PubMed ID: 14753747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenesis of periodontitis: role of cytokines in host response.
    Deo V; Bhongade ML
    Dent Today; 2010 Sep; 29(9):60-2, 64-6; quiz 68-9. PubMed ID: 20973418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of Bone Resorption in Periodontitis.
    Hienz SA; Paliwal S; Ivanovski S
    J Immunol Res; 2015; 2015():615486. PubMed ID: 26065002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone cell interactions and regulation by inflammatory mediators.
    Oates TW; Cochran DL
    Curr Opin Periodontol; 1996; 3():34-44. PubMed ID: 8624568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-inflammatory, anti-osteoclastic, and antioxidant activities of genistein protect against alveolar bone loss and periodontal tissue degradation in a mouse model of periodontitis.
    Bhattarai G; Poudel SB; Kook SH; Lee JC
    J Biomed Mater Res A; 2017 Sep; 105(9):2510-2521. PubMed ID: 28509410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of alveolar bone destruction in periodontitis.
    Schwartz Z; Goultschin J; Dean DD; Boyan BD
    Periodontol 2000; 1997 Jun; 14():158-72. PubMed ID: 9567970
    [No Abstract]   [Full Text] [Related]  

  • 11. Extracellular ATP is a key modulator of alveolar bone loss in periodontitis.
    Binderman I; Gadban N; Yaffe A
    Arch Oral Biol; 2017 Sep; 81():131-135. PubMed ID: 28528307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The osteoclast and periodontitis.
    Sterrett JD
    J Clin Periodontol; 1986 Apr; 13(4):258-69. PubMed ID: 3519690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ac45 silencing mediated by AAV-sh-Ac45-RNAi prevents both bone loss and inflammation caused by periodontitis.
    Zhu Z; Chen W; Hao L; Zhu G; Lu Y; Li S; Wang L; Li YP
    J Clin Periodontol; 2015 Jul; 42(7):599-608. PubMed ID: 25952706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cytokine network involved in the host immune response to periodontitis.
    Pan W; Wang Q; Chen Q
    Int J Oral Sci; 2019 Nov; 11(3):30. PubMed ID: 31685798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of tumour necrosis factor-α on bone cells involved in periodontal alveolar bone loss; osteoclasts, osteoblasts and osteocytes.
    Algate K; Haynes DR; Bartold PM; Crotti TN; Cantley MD
    J Periodontal Res; 2016 Oct; 51(5):549-66. PubMed ID: 26667183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mediators of periodontal osseous destruction and remodeling: principles and implications for diagnosis and therapy.
    McCauley LK; Nohutcu RM
    J Periodontol; 2002 Nov; 73(11):1377-91. PubMed ID: 12479643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zanthoxylum piperitum reversed alveolar bone loss of periodontitis via regulation of bone remodeling-related factors.
    Kim MH; Lee HJ; Park JC; Hong J; Yang WM
    J Ethnopharmacol; 2017 Jan; 195():137-142. PubMed ID: 27777167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokines and prostaglandins in immune homeostasis and tissue destruction in periodontal disease.
    Gemmell E; Marshall RI; Seymour GJ
    Periodontol 2000; 1997 Jun; 14():112-43. PubMed ID: 9567968
    [No Abstract]   [Full Text] [Related]  

  • 19. Functional human T-cell immunity and osteoprotegerin ligand control alveolar bone destruction in periodontal infection.
    Teng YT; Nguyen H; Gao X; Kong YY; Gorczynski RM; Singh B; Ellen RP; Penninger JM
    J Clin Invest; 2000 Sep; 106(6):R59-67. PubMed ID: 10995794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SOCS-3 Regulates Alveolar Bone Loss in Experimental Periodontitis.
    Papathanasiou E; Kantarci A; Konstantinidis A; Gao H; Van Dyke TE
    J Dent Res; 2016 Aug; 95(9):1018-25. PubMed ID: 27126447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.